US Bancorp’s Sensus Healthcare SRTS Stock Holding History

US Bancorp’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,500	Closed	-$16K	–	3784
2019 Q4	$16K	Buy	+4,500	New	+$20.4K	﹤0.01%	2971

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RWM

Rench Wealth Management Denton, Texas $332M AUM 25.74% 1-Year Est. Return

US Bancorp's SRTS Position: Q1 2020 in Review

US Bancorp sold out of Sensus Healthcare (SRTS) in Q1 2020, closing a stake of 4,500 shares — an estimated $16K sold.

US Bancorp first reported a position in SRTS in Q4 2019 and held it in 1 quarter. The position peaked at $16K in Q4 2019. 20 funds tracked by Wall St. Rank hold SRTS as of Q1 2020.

US Bancorp reported no remaining Sensus Healthcare position as of Q1 2020 after selling out during the quarter.
US Bancorp sold 4,500 Sensus Healthcare shares in Q1 2020, an estimated $16K.
US Bancorp first reported a position in Sensus Healthcare in Q4 2019 and held it in 1 quarter.
US Bancorp's Sensus Healthcare position peaked at $16K in Q4 2019.
20 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2020.

Based on US Bancorp's 13F filing for Q1 2020, filed 13 May 2020.